Description

n-Methyl-n-[6-(Trifluoromethoxy)-1,3-Benzothiazol-2-Yl]Glycine is a high-value, specialized benzothiazole derivative, recognized for its unique trifluoromethoxy-substituted heterocyclic structure. This compound is critical for advanced research and development, offering a versatile scaffold for creating novel molecules with targeted properties. It is primarily sought after by pharmaceutical and agrochemical R&D teams for use as a key intermediate in the synthesis of active ingredients and functional materials.

Application

• Pharmaceutical Intermediate: Serves as a crucial building block in the synthesis of novel drug candidates, particularly in medicinal chemistry programs targeting CNS disorders, inflammation, or metabolic diseases.
• Agrochemical Research: Used in the development of next-generation pesticides and herbicides, where the benzothiazole and trifluoromethoxy moieties can contribute to biological activity and environmental stability.
• Material Science Precursor: Acts as a monomer or functional additive in the development of advanced polymers, liquid crystals, or organic electronic materials.
• Biochemical Tool Compound: Employed in life science research as a probe or inhibitor to study specific enzymatic pathways or biological mechanisms.
• Custom Synthesis & Contract Manufacturing: A key starting material for fine chemical manufacturers offering bespoke synthesis services for clients in regulated industries.

Basic Information

Product Name	n-Methyl-n-[6-(Trifluoromethoxy)-1,3-Benzothiazol-2-Yl]Glycine
CAS No.	1353000-13-1
Molecular Formula	C₁₂H₉F₃N₂O₃S
Molecular Weight	318.27 g/mol
Synonyms	2-[(6-(Trifluoromethoxy)-1,3-benzothiazol-2-yl)(methyl)amino]acetic acid; Glycine, N-methyl-N-[6-(trifluoromethoxy)-2-benzothiazolyl]-; N-Methyl-N-(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)glycine; Methyl(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)aminoacetic acid; 1353000-13-1; Benzothiazole glycine derivative; Trifluoromethoxy benzothiazole glycine
EINECS	Contact for details

Quality Control

Our n-Methyl-n-[6-(Trifluoromethoxy)-1,3-Benzothiazol-2-Yl]Glycine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for research and development applications. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from heat, sparks, and open flame. The compound is light-sensitive and should be stored away from light as indicated.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.